HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-oxo-1,2,4-oxadiazoline → HCID 178461245, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-oxo-1,2,4-oxadiazoline | HCID 135424770 | — |
| Reactant | HCID 178461247 | HCID 178461247 | — |
| Product | HCID 178461245 | HCID 178461245 | — |
Reaction Steps
Using a procedure analogous to that described in Example 3.94 (Step 3), and starting with 4-(5-chloropyridin-3-yl)-2-((2-fluorophenyl)amino)-N-hydroxy-3-((trans-4-methylcyclohexyl)methyl)-3H-imidazo[4,5-c]pyridine-6-carboximidamide, 3-(4-(5-chloropyridin-3-yl)-2-(2-fluorophenyl)amino)-3-((trans-4-methylcyclohexyl)methyl)-3H-imidazo[4,5-c]pyridin-6-yl)-1,2,4-oxadiazol-5(4H)-one (TFA salt) was prepared. MS ESI calc'd. for C27H25ClFNγO2 [M+H]+ 534. found 534. 1H NMR (500 MHz, DMSO-d6) δ 12.83 (s, 1H), 9.27 (s, 1H), 8.83 (m, J=20.7, 2H), 8.39 (s, 1H), 7.81 (s, 1H), 7.65 (m, 1H), 7.26 (m, 3H), 3.85 (s, 2H), 1.44 (d, 2H), 1.07 (m, 2H), 0.71 (m, J=6.5, 7H), 0.54 (m, 2H)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08846657B2 |
| Source dataset | uspto-grants-2014_09 |
| ORD ID | ord-baa026e9e10f417ea3d772417493e71a |
| Source note | uspto-grants-2014_09 |